174 related articles for article (PubMed ID: 25009948)
1. The role of inflammation in contrast-induced nephropathy.
Kwasa EA; Vinayak S; Armstrong R
Br J Radiol; 2014 Sep; 87(1041):20130738. PubMed ID: 25009948
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
[TBL] [Abstract][Full Text] [Related]
3. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
[TBL] [Abstract][Full Text] [Related]
4. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
[TBL] [Abstract][Full Text] [Related]
5. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
6. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Gu G; Yuan X; Zhou Y; Liu D; Cui W
BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography.
Mitchell AM; Jones AE; Tumlin JA; Kline JA
Acad Emerg Med; 2012 Jun; 19(6):618-25. PubMed ID: 22687176
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients.
Lee J; Cho JY; Lee HJ; Jeong YY; Kim CK; Park BK; Sung DJ; Kang BC; Jung SI; Lee EJ; Yi BH; Park SJ; Kim JC; Jung DC; Sung CK; Kim Y; Lee Y; Kim SH; Yoon SK; Park BJ; Kim SH; ;
Korean J Radiol; 2014; 15(4):456-63. PubMed ID: 25053905
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
10. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Weisbord SD; Hartwig KC; Sonel AF; Fine MJ; Palevsky P
Catheter Cardiovasc Interv; 2008 Jun; 71(7):879-85. PubMed ID: 18412255
[TBL] [Abstract][Full Text] [Related]
11. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
12. Association between contrast-induced nephrotoxicity and contrast enhanced computed tomography followed by endoscopic retrograde cholangiopancreatography.
Shinoura S; Tokushige A; Chinen K; Mori H; Kato S; Ueda S
Eur J Radiol; 2020 Aug; 129():109074. PubMed ID: 32473539
[TBL] [Abstract][Full Text] [Related]
13. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
14. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
16. Laboratory Predictors of Contrast-Induced Nephropathy After Neurointervention: A Prospective 3-Year Observational Study.
Kim H; Jo K
World Neurosurg; 2020 Mar; 135():e77-e82. PubMed ID: 31698123
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized.
Caruso M; Balasus F; Incalcaterra E; Ruggieri A; Evola S; Fattouch K; Bracale UM; Amodio E; Novo G; Andolina G; Novo S
Intern Med; 2011; 50(9):983-9. PubMed ID: 21532220
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies.
Carstensen M; Keer D; Rempel J; Jeon P; Barrett B
Can Assoc Radiol J; 2012 Aug; 63(3):177-82. PubMed ID: 22030305
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for contrast-induced nephropathy after coronary angiography.
Kumar S; Nair RK; Aggarwal N; Abbot AK; Muthukrishnan J; Kumar KV
Saudi J Kidney Dis Transpl; 2017; 28(2):318-324. PubMed ID: 28352014
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization.
Shukla AN; Juneja M; Patel H; Shah KH; Konat A; Thakkar BM; Madan T; Prajapati J
Indian Heart J; 2017; 69(3):311-315. PubMed ID: 28648419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
